Type to search


DE222 Honoree: Michael Fleming

Avatar photo

Title: President

Michael Fleming

Workplace: Delaware BioScience Association

Alma Maters: University of Delaware, John Hopkins University

Boards: Delaware Technology Park, ChristianaCare’s Gene Editing Institute, Council of State Bioscience Associations

Q&A: Best advice for your younger self? “There will be a new company that comes along in a few years called Appled. Borrow heavily and buy as much of their stock as you possibly can. Trust me.”

Michael Fleming, a biopharmaceutical industry veteran who spent 18 years with global biopharmaceutical company GlaxoSmithKline (GSK), was appointed president of the Delaware BioScience Association in June 2020. The industry association represents 160 companies in the burgeoning industry in the First State, hosting monthly meetings to connect members, producing reports highlighting the growth of the industry, and advocating for policy changes. He’s well-suited to the role, having started his career as Wilmington state office director for the late U.S. Sen. William V. Roth Jr. Under Fleming’s leadership Del Bio has increased its visibility through hosting the state’s first daylong conference for the industry, drawing hundreds of attendees from around the region to Wilmington.


Get the free DBT email newsletter  

Follow the people, companies and issues that matter most to business in Delaware.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Premier Digital Partners

© 2024 Delaware Business Times

Flash Sale! Subscribe to Delaware Business Times and save 50%.

Limited time offer. New subscribers only.

Limited time offer. New subscribers only.


Subscribe to Delaware Business Times and save 50%